Clinical Adventurer
When seconds count, your patient’s lab results can be the difference between catching a heart attack early or missing a silent killer. In this episode, we break down cardiac biomarkers — what they really mean, how to interpret them, and why troponins reign supreme in today’s high-stakes cardiac care. We’ll walk you through the science, the pitfalls, and the nursing implications so you can make sense of those critical labs in real time. 🧠 Key Topics Covered: * What Are Cardiac Biomarkers? * Substances released during cardiac muscle injury * Their role in diagnosing Acute Myocardial Infarction (AMI) and Acute Coronary Syndromes (ACS) * Troponin I and T – The Gold Standard: * Why they replaced AST, LDH, and CK-MB * Sensitivity, specificity, and timing of elevation * Clinical relevance of high-sensitivity troponin assays * Other Biomarkers in Context: * CK-MB and myoglobin: When they’re still used * BNP and NT-proBNP: For heart failure assessment (vs ischemia) * Timing and Trends Matter: * Serial troponin testing and rise/fall patterns * How early peaks and delayed elevations affect diagnosis * False Positives and Interfering Factors: * Sepsis, renal failure, pulmonary embolism, and chronic disease * Pre-analytical issues: Hemolysis, improper timing, and specimen handling * Diagnostic Criteria for AMI (Fourth Universal Definition): * Troponin changes + clinical signs + ECG changes * Type 1 vs Type 2 MI differentiation * Nursing and Interprofessional Implications: * When to alert the provider * How to prepare patients for serial testing * Collaborating with lab, cardiology, and emergency teams for timely action
40 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Clinical Adventurer!